The prevalence of antiheart antibody using an indirect immunofluorescent technique with infant heart muscle as substrate was determined in iI patients with idiopathic hypertrophic subaortic stenosis. For comparison, sera from patients with congestive cardiomyopathy, coronary artery disease, congenital heart disease, chronic rheumatic heart disease, and normal subjects were studied. There was a significant increase in the prevalence of antiheart antibody in patients with idiopathic hypertrophic subaortic stenosis (82%) compared to the other groups. The degree of intensity offluorescence of the patients' sera correlated with periods of increased symptomatology. Conversely, with improvement and a stable clinical course there was a qualitative reduction in reactivity of sera with heart tissue. The mechanisms for the development of antiheart antibody are unknown. It may result from one or more insults or injuries to heart tissue. Upper respiratory infections may be associated with onset and subsequent aggravation of cardiac symptoms in some patients with idiopathic subaortic stenosis.
Idiopathic hypertrophic subaortic stenosis is a form of cardiomyopathy which has been recognized in both an acquired sporadic form and a familial form (Frank and Braunwald, I968) . Aetiological events associated with it have not been elucidated, though pathophysiological mechanisms and natural history are becoming increasingly clear (Burchell, I97I Center during the 2-year period I968 to I969 were studied. There were 4 women, 6 men and a boy, whose ages ranged from 8 to 58 years ( Results Two types of fluorescence were encountered in these sera: sarcolemmal and subsarcolemmal. Sarcolemmal staining occurred along the margins and periphery of the cardiac fibres. Subsarcolemmal immunofluorescence occurred in deposits immediately within the fibre (Fig.) . Both of these patterns were usually observed in the patients with idiopathic subaortic stenosis. Sarcolemmal staining, when it occurred alone, was generally i to 2+ in intensity with a titre of I: I0 or less. Subsarcolemmal staining was seen with more intense immunofluorescense graded as 3 to 4+. Sera with subsarcolemmal staining were positive to a titre of I: 25 or less. IgG was the most frequent immunoglobulin associated with antiheart antibody positivity and occurred in all 9 patients with idiopathic hypertrophic subaortic stenosis, 5 of 6 with idiopathic congestive cardiomyopathy, and 3 of 4 with rheumatic heart disease. Table 2 shows the results of these tests observed in the patient groups. Nine of ii patients with idiopathic hypertrophic subaortic stenosis, 6 of 35 with cardiomyopathy, 4 of 24 with rheumatic heart disease, none of 17 with coronary artery disease, none of i i with congenital heart disease, and i of 50 normal subjects were positive for antiheart antibody. Sarcolemmal and subsarcolemmal staining were observed in 6 of 7 symptomaticpatients; theothermildly symptomatic patient (Class II) showed a negative response. In contrast, sera from 3 of 4 non-symptomatic patients with idiopathic hypertrophic subaortic stenosis were only faintly positive (i +) with predominantly sarcolemmal staining; the serum of the fourth patient was negative. Sarcolemmal staining was observed in 4 of 6 patients with cardiomyopathy, and in the other 2 only slightly increased intensity of staining (2 + ) of both sarcolemmal and subsarcolemmal types was observed. The normal subject with positive antiheart antibody showed only sarcolemmal staining.
It was possible in a follow-up study to examine sera from 7 patients with idiopathic hypertrophic subaortic stenosis, all initially positive for antiheart antibody. In 3 of the 7, the tests were negative, and in 2 the degree of fluorescence was conspicuously reduced compared to earlier results. A negative test or a decrease in degree of fluorescence in the followup study was associated clinically with symptomatic improvement in all but i patient ( reduction in the degree of fluorescence for antiheart antibody. Clinical improvement was maintained and 2 years later he showed no evidence of circulating antiheart antibody. The other patient's course (Case 4) was aggravated by frequent chest infections. A programme of regular prophylactic antibiotic therapy was instituted, and for the ensuing 3 years she was free of infections and has maintained a clinically stable cardiac course. Serological studies periodically during this time showed no recurrence of antiheart antibody.
Discussion
Antiheart antibody has been observed in a number of cardiac and noncardiac conditions (Kaplan and Frengley, I969). These authors have emphasized the nonspecificity of antiheart antibody and have suggested that the variable frequency of occurrence of antiheart antibody in published reports was related partly to the nonuniformity of antigenic composition of the substrates used and the different methods employed.
The mechanism for its production in idiopathic hypertrophic subaortic stenosis is not understood. It may be a consequence of injury to heart tissue as in its occurrence after severe ischaemia or infarction (Heine et al., I966) . Since antiheart antibody has not been found in the sera of all of our patients, it lacks specificity from a pathogenic or diagnostic standpoint. Unique among our patients with hyper- trophic subaortic stenosis is the higher frequency of antiheart antibody and the enhanced antiheart muscle fluorescence observed during periods of increased symptomatology, unlike that in cardiomyopathy patients (Das, Cassidy, and Petty, I972) .
With clinical improvement there appeared to be a corresponding decrease in detectability of antiheart antibody and in intensity of immunofluorescence (Table 3) . The reasons for these phenomena are unclear. Van der Geld (I964) detected antiheart antibody in patients with postcardiotomy and postmyocardial infarction syndromes particularly when they were symptomatic, but not during symptom-free periods. Similarly, we have recently observed a higher prevalence of antiheart antibody in patients with infective endocarditis complicated by heart failure (Das, Cassidy, and Willis, I97I Further studies would be necessary to determine if autoimmune mechanisms were indeed involved in hypertrophic subaortic stenosis. Virus infection might also be related to the development of autoimmunity (Lachmann, I968) . Upper respiratory infection, though aetiologically unclarified, appeared to play an important role in the clinical course of the disease in 2 of our patients. 
